deltatrials
Unknown PHASE3 NCT00139165

Long-Term Treatment of Collagenous Colitis With Budesonide

Long-Term Treatment of Collagenous Colitis With Budesonide. Prospective, Doubleblind Placebo-Controlled Trial.

Sponsor: AstraZeneca

Conditions Collagenous Colitis
Interventions Budesonide sigmoidoscopy
Updated 5 times since 2017 Last updated: Mar 3, 2008 Started: Sep 30, 2004 Completion: Mar 31, 2006

A PHASE3 clinical study on Collagenous Colitis, this trial is ongoing. The trial is conducted by AstraZeneca and has accumulated 5 data snapshots since 2004. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE3

    Status: Unknown Status → Unknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Unknown Status PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Unknown Status PHASE3

    First recorded

Sep 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • AstraZeneca
  • Bonderup, Ole K., M.D.
Data source: Bonderup, Ole K., M.D.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Aalborg, Denmark
  • • Aarhus, Denmark